DESCRIPTION (Adapted from the Applicant's Abstract): The anaerobic
organism, Bacteroides fragilis is exceptionally resistant to the toxic
effects of oxygen and other oxidative stress. This resistance can be
attributed to induction of an oxidative stress response (OSR) and this
response will be studied to document its role in the pathogenesis of
Bacteroides fragilis infection. It is expected that new mechanisms of
free radical protection and novel antioxidant defense strategies will
be uncovered. This idea is supported by the fact that B. fragilis
diverged very early from other eubacteria and has independently evolved
the ability to survive extended exposure to oxygen. Further, since this
is an anaerobe, it is likely to have stringent requirements for oxygen
protection that have resulted in the development of unique highly
protective antioxidants. The long term goals of this research are to
understand the basic physiological and genetic processes responsible for
tolerance of B. fragilis to oxidative stress and to determine how these
contribute to virulence. The objectives for this proposal are: 1) Define
and characterize the OSR at the protein and genetic levels. Initially,
attention will focus on a subset of the OSR, resistance to H2O2 and
peroxides (HPR). A set of HPR genes will be cloned and analyzed, and
these data will be used to establish a catalog of HPR proteins expressed
during the course of oxidative stress. 2) Regulation of the HPR regulon
will be studied initially using a model system employing the catalase
gene, katB. This will focus on transcriptional regulation and the
identification of oxidative stress regulatory molecules. The system will
be expanded to include the HPR genes as they become available. 3)
Determine the effect of specific mutations in HPR-controlled genes on
survival to oxidative stress. Mutants in one or more of these genes will
be constructed by allelic exchange and tested for their ability to
survive various forms of oxidative stress. Mutants will be subjected to
a variety of biochemical tests to determine their mechanism of
protection e.g. DNA repair or macromolecule protection. 4) The regulator
responsible for control of the HPR regulon will be cloned and its role
in the overall OSR will be determined.
National Institute of Allergy and Infectious Diseases
CFDA Code
856
DUNS Number
607579018
UEI
HWPEKM8VFTJ9
Project Start Date
01-December-1998
Project End Date
30-November-2003
Budget Start Date
01-December-2001
Budget End Date
30-November-2003
Project Funding Information for 2002
Total Funding
$189,412
Direct Costs
$148,870
Indirect Costs
$40,542
Year
Funding IC
FY Total Cost by IC
2002
National Institute of Allergy and Infectious Diseases
$189,412
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI040588-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI040588-04
Patents
No Patents information available for 5R01AI040588-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI040588-04
Clinical Studies
No Clinical Studies information available for 5R01AI040588-04
News and More
Related News Releases
No news release information available for 5R01AI040588-04
History
No Historical information available for 5R01AI040588-04
Similar Projects
No Similar Projects information available for 5R01AI040588-04